MetaCap

Eledon Pharmaceuticals (ELDN) vs Emmis Acquisition (EMIS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Eledon Pharmaceuticals (ELDN) has outperformed Emmis Acquisition (EMIS) over the past year, gaining 23.6% versus a gain of 4.4%. Emmis Acquisition is the larger company by market cap ($163.4 million vs $150.3 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ELDN+23.61%EMIS+4.39%
+202%+96%-10%
Nov 21, 20251 yearNov 20, 2026
ELDN-48.85%EMIS+4.60%
+28%-17%-63%
Oct 20, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ELDN versus EMIS key metrics
MetricELDNEMIS
Share price$1.78$10.36
Market cap$150.34M$163.36M
1-day change-6.32%+0.15%
YTD return+17.88%+4.07%
1-year return+23.61%+4.39%
5-year return-65.64%—
EPS (TTM)$-0.73—
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-45.62M—
52-week high$4.49$10.38
52-week low$1.39$9.92
Distance from 52-week high-60.36%-0.24%
Analyst consensusstrong_buy—
Avg. price target upside+405.62%—
Average volume931.77K16.19K
Shares outstanding84.46M11.94M
Employees33—
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ELDN has outperformed EMIS by 19.2 percentage points over the past year.

About Eledon Pharmaceuticals

ELDN stock →

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company.

Health Care · Biotechnology: Pharmaceutical Preparations · 33 employees

About Emmis Acquisition

EMIS stock →

Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.

Health Care · Biotechnology: Pharmaceutical Preparations

ELDN vs EMIS FAQ

Which is bigger, Eledon Pharmaceuticals or Emmis Acquisition?

Emmis Acquisition (EMIS) is larger, with a market capitalization of $163.36M compared with $150.34M for Eledon Pharmaceuticals (ELDN).

Which stock has performed better over the past year, ELDN or EMIS?

ELDN returned +23.61% over the past 12 months, compared with +4.39% for EMIS (price return, excluding dividends). Past performance does not predict future results.

Are Eledon Pharmaceuticals and Emmis Acquisition in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons